Cite
HARVARD Citation
Hengeveld, P. et al. (n.d.). P652: MEASURING MINIMAL RESIDUAL DISEASE BEYOND 10-4 THROUGH IGHV LEADER-BASED NEXT GENERATION SEQUENCING IMPROVES PROGNOSTIC STRATIFICATION IN CHRONIC LYMPHOCYTIC LEUKEMIA. HemaSphere. pp. 550-551. [Online].